K Number
K181579

Validate with FDA (Live)

Manufacturer
Date Cleared
2018-07-26

(41 days)

Product Code
Regulation Number
886.5916
Reference & Predicate Devices
Predicate For
N/A
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear are indicated for the correction of refractive ametropia (myopia, astigmatism and presbyopia) in aphakic and not aphakic persons with non-diseased eyes. Also, the lenses may be prescribed in otherwise non-diseased eyes that require a gas permeable contact lens for the management of irregular corneal conditions such as keratoconus, pellucid marginal degeneration, or following penetrating keratoplasty or refractive (e.g., LASIK) surgery. The lenses may be disinfected using a chemical disinfection system only.

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K is indicated for daily wear in an orthokeratology fitting program for the temporary reduction of myopia of up to 5.00 diopters in non-diseased eyes. The lenses may be disinfected using a chemical disinfection system only.

Note: To maintain the orthokeratology effect of myopia reduction, lens wear must be continued on a prescribed wearing schedule.

Device Description

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear and eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K are lathe cut from one of the following hydrophobic. FDA Group #3 fluoro-silicone acrylate materials: hexafocon A, hexafocon B, or oprifocon A-with the following properties: Refractive Index, Water Content, Specific Gravity, Wetting Angle, Oxygen Permeability (Dk) ISO/FATT Method (cm2/sec) (ml O2/ml x mm Hg @ 35°C), Contain one or more of the following color additives conforming to: 21 CFR Part 73 & 74, Subpart D.

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear are available in the following lens parameters: Base Curve, Center Thickness, Diameter, Spherical Power, Cylindrical Power, Cylindrical Axis, Multifocal Power.

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K are available in the following lens parameters: Base Curve, Center Thickness, Diameter, Secondary Curves, Peripheral Curves, Spherical Power, Aspheric Lens Eccentricity.

AI/ML Overview

This document is a 510(k) Premarket Notification for the eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear and eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K.

The provided text does not describe a study that uses AI or machine learning models to meet acceptance criteria, but rather focuses on substantial equivalence to existing predicate devices for rigid gas permeable contact lenses. Therefore, I cannot extract information related to AI/ML model acceptance criteria, performance, sample sizes for test/training sets, expert adjudication, or MRMC studies from this document.

The document primarily covers:

  • Device Description: Materials, properties, and available parameters of the contact lenses.
  • Intended Use/Indications for Use: Correction of refractive ametropia (myopia, hyperopia, astigmatism, presbyopia), management of irregular corneal conditions, and temporary reduction of myopia for Ortho-K.
  • Predicate Devices: Lists several "Boston" brand contact lenses as predicate devices.
  • Substantial Equivalence: Argues that the eLens is substantially equivalent to the predicate devices based on common classification, product code, FDA Group #, USAN, production method (lathe-cut), actions, intended use, and indications for use.
  • Performance Data: States that non-clinical and clinical performance data have been addressed by reference to the predicate devices and in previous applications.

Therefore, I cannot fulfill the request to discuss acceptance criteria and study proving the device meets those criteria, as the document does not contain information about an AI/ML-based study.

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image contains two logos. On the left is the Department of Health & Human Services logo, which features a stylized human figure. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue.

July 26, 2018

E&E Optics Inc. % Bret Andre Principal Consultant EyeReg Consulting, Inc. 6119 Canter Ln West Linn, OR 97068

Re: K181579

Trade/Device Name: eLens (hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lens for Daily Wear. eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lens for Daily Wear Ortho-K Regulation Number: 21 CFR 886.5916 Regulation Name: Rigid Gas Permeable Contact Lens Regulatory Class: Class II Product Code: HOD. MUW Dated: June 13, 2018 Received: June 15, 2018

Dear Bret Andre:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

{1}------------------------------------------------

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/CombinationProducts/GuidanceRegulatoryInformation/ucm597488.html; good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm.

For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).

Sincerely.

J Angelo Green -S

for Malvina B. Eydelman, M.D. Director Division of Ophthalmic and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Indications for Use

510(k) Number (if known) K181579

Device Name

eLens (hexafocon A. hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear; eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K

Indications for Use (Describe)

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear are indicated for the correction of refractive ametropia (myopia, astigmatism and presbyopia) in aphakic and not aphakic persons with non-diseased eyes. Also, the lenses may be prescribed in otherwise non-diseased eyes that require a gas permeable contact lens for the management of irregular corneal conditions such as keratoconus, pellucid marginal degeneration, or following penetrating keratoplasty or refractive (e.g., LASIK) surgery. The lenses may be disinfected using a chemical disinfection system only.

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K is indicated for daily wear in an orthokeratology fitting program for the temporary reduction of myopia of up to 5.00 diopters in non-diseased eyes. The lenses may be disinfected using a chemical disinfection system only.

Note: To maintain the orthokeratology effect of myopia reduction, lens wear must be continued on a prescribed wearing schedule.

Type of Use (Select one or both, as applicable)

☑ Recreation Use (Part 91 CFR 201.5(b))
☐ On-The-Spot Use (91 CFR 201.5(c))

2 Prescription Use (Part 21 CFR 801 Subpart D)

Over-The-Counter Use (21 CFR 801 Subpart C)

CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

510 (k) SUMMARY OF SAFETY AND EFFECTIVENESS

This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR 807.92.

The assigned 510(k) number is: K181579

I. SUBMITTER

  • July 11th, 2018 Date Prepared:
  • Name: E&E Optics Inc. Address: 1795 E. Holt Blvd, Unit 104 Ontario, CA 91761 United States Contact Person: Bonnie Wan President (909) 391-8330 Phone number: Consultant: Bret Andre EyeReg Consulting, Inc. 6119 Canter Ln.

West Linn, OR 97068 Phone number: (503) 372-5226

II. DEVICE

Trade Name:eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas PermeableContact Lenses for Daily Wear;eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas PermeableContact Lenses for Daily Wear Ortho-K
CommonName:Daily wear rigid gas permeable (hydrophobic) contact lens;Daily wear rigid gas permeable (hydrophobic) contact lens (Orthokeratology)
ClassificationName:Rigid gas permeable contact lens. (21 CFR 886.5916)
RegulatoryClass:Class II
Product Code:HQD; MUW

{4}------------------------------------------------

III. PREDICATE DEVICE

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear and eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K are substantially equivalent to the following predicate devices:

  • . "Boston XO (hexafocon A) Contact Lens for Daily Wear Orthokeratology" By Bausch + Lomb Inc. 510(k) number; K001960
  • . "Boston Equalens II (oprifocon A) Contact Lens for Daily Wear Orthokeratology" By Bausch + Lomb Inc. 510(k) number: K003933
  • . "Boston XO2 (hexafocon B) Contact Lens for Daily Wear (Orthokeratology)" By Bausch + Lomb Inc. 510(k) number: K071266
  • 트 "Boston XO (Hexafocon A) Rigid Gas Permeable Contact Lens" By Bausch + Lomb Inc. 510(k) number; K071043
  • . "Acuity 85 (Oprifocon A) Rigid Gas Permeable Contact Lens" By Acuity Polymers Inc. 510(k) number; K170001

DEVICE DESCRIPTION IV.

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear and eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K are lathe cut from one of the following hydrophobic. FDA Group #3 fluoro-silicone acrylate materials: hexafocon A, hexafocon B, or oprifocon A-with the following properties:

HEXAFOCON AHEXAFOCON BOPRIFOCON A
Refractive Index1.4141.4241.423
Water Content<1%<1%<1%
Specific Gravity1.2661.191.24
Wetting Angle49°38°30°
Oxygen Permeability(Dk) ISO/FATT Method(cm2/sec) (ml O2/ml x mm Hg @ 35°C)$100 \times 10^{-11}$$141 \times 10^{-11}$ (edge corrected)$161 \times 10^{-11}$ (non-edgecorrected)$85 \times 10^{-11}$
Contain one or more of the following coloradditives conforming to:21 CFR Part 73 & 74, Subpart DD&C Green No. 6, C.I. SolventYellow No. 18, and D&C VioletNo. 2D&C Green No. 6, C.I. SolventYellow No. 18, and D&C VioletNo. 2D & C Green No. 6, FD & C RedNo. 17,CI Solvent Yellow 18

{5}------------------------------------------------

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear are available in the following lens parameters:

ParameterRangeTolerance
Base Curve4.00mm to 9.00mm± 0.05 mm
Center Thickness0.20mm to 0.50mm± 0.02 mm
Diameter7.00mm to 21.00mm± 0.10mm
Spherical Power-20.00 D to +20.00 D(in 0.25D steps)± 0.12 (0 to = 5D)<br ± 0.18 (5 to = 10.0D)<br ± 0.25 (10 to = 15D)<br ± 0.37 (15 to = 20D)<br ± 0.50 (over 20D)
Cylindrical PowerUp to -9.00 D(in 0.25 D steps)± 0.25 (0 to = 2D)<br ± 0.37 (2 to = 4D)<br ± 0.50 (over 4D)
Cylindrical Axis1° to 180° (in 1º steps)± 5°
Multifocal Power+1.00 D to 3.75 D(in 0.25 D steps)± 0.25D

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K are available in the following lens parameters:

ParameterRangeTolerance
Base Curve6.50mm to 11.00mm± 0.05 mm
Center Thickness0.10mm to 0.30mm (low minus lens)0.20mm to 0.70mm (plus lens)± 0.02 mm
Diameter6.50mm to 11.50mm± 0.10mm
Secondary Curves0.10mm to 2.00mm (flatter orsteeper than base curve)± 0.10mm
Peripheral Curves0.10mm to 2.00mm (flatter orsteeper than base curve)± 0.10mm
Spherical Power-10.00 D to +30.00 D(in 0.25D steps)± 0.12 (0 to = 5D)<br ± 0.18 (5 to = 10.0D)<br ± 0.25 (10 to = 15D)<br ± 0.37 (15 to = 20D)<br ± 0.50 (over 20D)
Aspheric Lens Eccentricity-1.5 to 1.5 (oblate, prolate, ortangent conic)

{6}------------------------------------------------

V. INDICATIONS FOR USE

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear are indicated for the correction of refractive ametropia (myopia, hyperopia, astigmatism and presbyopia) in aphakic and not aphakic persons with non-diseased eyes. Also, the lenses may be prescribed in otherwise non-diseased eyes that require a gas permeable contact lens for the management of irregular corneal conditions such as keratoconus, pellucid marginal degeneration, or following penetrating keratoplasty or refractive (e.g., LASIK) surgery. The lenses may be disinfected using a chemical disinfection system only.

The eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K is indicated for daily wear in an orthokeratology fitting program for the temporary reduction of myopia of up to 5.00 diopters in non-diseased eyes. The lens may be disinfected using a chemical disinfection system only.

Note: To maintain the orthokeratology effect of myopia reduction, lens wear must be continued on a prescribed wearing schedule.

COMPARISON OF TECHNOLOGICAL CHARACTERISTICS WITH PREDICATE VI. DEVICE

The following matrix illustrates the production method, intended use and materials of the eLens (hexafocon A. hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear and eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K, as well as the predicate device.

eLens RGPContact LensesBoston XO RGPContact LensBoston XO2 RGPContact LensBoston Equalens IIRGP Contact Lens
Subject DevicePredicate Device(K001960)Predicate Device(K071266)Predicate Device(K003933)
ClassificationSame as predicateClass IILenses, Rigid Gas Permeable,Daily Wear21 CFR 886.5916Class IILenses, Rigid Gas Permeable,Daily Wear21 CFR 886.5916Class IILenses, Rigid Gas Permeable,Daily Wear21 CFR 886.5916
Product CodeSame as predicateHQD; MUWHQD; MUWHQD; MUW
FDA Group #Same as predicateGroup # 3 FluoroSilicone AcrylateGroup # 3 FluoroSilicone AcrylateGroup # 3 FluoroSilicone Acrylate
USANSame as predicatehexafocon Ahexafocon Boprifocon A
ProductionMethodSame as predicateLathe-CutLathe-CutLathe-Cut

Substantial Equivalence Matrix

{7}------------------------------------------------

ActionsSame as predicateThe contact lenses act as arefractive medium thatfocus light rays from nearand distant objects on theretina. (orthokeratology)The contact lenses act as arefractive medium thatfocus light rays from nearand distant objects on theretina. (orthokeratology)The contact lenses act as arefractive medium thatfocus light rays from nearand distant objects on theretina. (orthokeratology)
Intended UseSame as predicateDaily WearDaily WearDaily Wear
Indication for UseSame as predicateIndicated for the correction ofrefractive ametropia (myopia,hyperopia, astigmatism andpresbyopia) in aphakic and notaphakic persons with non-diseased eyes. Also, the lensesmay be prescribed in otherwisenon-diseased eyes that requirea gas permeable contact lensfor the management ofirregular corneal conditionssuch as keratoconus, pellucidmarginal degeneration, orfollowing penetratingkeratoplasty or refractive (e.g.,LASIK) surgery. Also,indicated for daily wear in anorthokeratology fittingprogram for the temporaryreduction of myopia of up to5.00 diopters in non-diseasedeyes.Indicated for the correction ofrefractive ametropia (myopia,hyperopia, astigmatism andpresbyopia) in aphakic andnot aphakic persons with non-diseased eyes. Also, thelenses may be prescribed inotherwise non-diseased eyesthat require a gas permeablecontact lens for themanagement of irregularcorneal conditions such askeratoconus, pellucidmarginal degeneration, orfollowing penetratingkeratoplasty or refractive(e.g., LASIK) surgery. Also.indicated for daily wear in anorthokeratology fittingprogram for the temporaryreduction of myopia of up to5.00 diopters in non-diseasedeyes.Indicated for the correction ofrefractive ametropia (myopia,hyperopia, astigmatism andpresbyopia) in aphakic andnot aphakic persons with non-diseased eyes. Also, thelenses may be prescribed inotherwise non-diseased eyesthat require a gas permeablecontact lens for themanagement of irregularcorneal conditions such askeratoconus, pellucidmarginal degeneration, orfollowing penetratingkeratoplasty or refractive(e.g., LASIK) surgery. Also,indicated for daily wear in anorthokeratology fittingprogram for the temporaryreduction of myopia of up to5.00 diopters in non-diseasedeyes.

VII. PERFORMANCE DATA

~ Non-Clinical Studies ~

The non-clinical performance data to establish the safety and effectiveness of contact lenses manufactured from hexafocon A, hexafocon B, and oprifocon A has been addressed by reference to the predicate devices.

~ Clinical Studies ~

Clinical performance data to demonstrate the safety and effectiveness of contact lenses manufactured from hexafocon A. hexafocon B. and oprifocon A has been addressed in previous applications.

VIII. CONCLUSIONS

Substantial Equivalence

Information presented in this Premarket Notification establishes that eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear and eLens (hexafocon A, hexafocon B and oprifocon A) Rigid Gas Permeable Contact Lenses for Daily Wear Ortho-K are as safe and effective as the predicate device when used in accordance with the labeled directions for use and for the proposed indication.

{8}------------------------------------------------

Risks and Benefits

The risks of the subject device are the same as those normally attributed to the wearing of rigid gas permeable (RGP) daily wear contact lenses. The benefits to the patient are the same as those for other RGP contact lenses.

§ 886.5916 Rigid gas permeable contact lens.

(a)
Identification. A rigid gas permeable contact lens is a device intended to be worn directly against the cornea of the eye to correct vision conditions. The device is made of various materials, such as cellulose acetate butyrate, polyacrylate-silicone, or silicone elastomers, whose main polymer molecules generally do not absorb or attract water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.